JAOA -- Table of Contents (October 2006, 106 [10])

LETTERS:

Nitric Oxide and Anandamide in OMT Research: George B. Stefano and Elliott J. Salamon, IV
J Am Osteopath Assoc 2006 106:588-589. [Full Text] [PDF]

Response: John M. McPartland
J Am Osteopath Assoc 2006 106:589. [Full Text] [PDF]

Unsubstantiated Superiority Claims for Rivastigmine Tartrate: Shiwan K. Shah and Paul M. Krueger
J Am Osteopath Assoc 2006 106:589-590. [Full Text] [PDF]

Mechanisms of Change: Animal Models in Osteopathic Medical Research: Michael M. Patterson
J Am Osteopath Assoc 2006 106:593-596. [Full Text] [PDF]

JAOA Now Requires Public Registration of Clinical Trials: Audrey K. Daniel
J Am Osteopath Assoc 2006 106:598. [Full Text] [PDF]

Significance of Differences in Patency Among Cranial Sutures: Rosanna C. Sabini and David E. Elkowitz
J Am Osteopath Assoc 2006 106:600-604. [Abstract] [Full Text] [PDF]
The authors grade the patency of the external coronal, lambdoid, and sagittal sutures of 36 cadaver skulls. They also assess the relationships among suture grade and location as well as cadaver sex and age. Significant differences were found when comparing suture grade with suture location. A greater degree of patency was found in lambdoid sutures compared with coronal and sagittal sutures. The authors attribute this finding to the greater number of muscles that affect the occipital lobe.

Incidence of Iatrogenesis Associated With Osteopathic Manipulative Treatment of Pediatric Patients: Natalie M. Hayes and Todd A. Bezilla
J Am Osteopath Assoc 2006 106:605-608. [Abstract] [Full Text] [PDF]
Because no studies exist documenting the safety of osteopathic manipulative treatment (OMT) in pediatric patients, the authors sought to determine the incidence of iatrogenesis (ie, aggravations and complications derived from OMT) in this population by conducting a retrospective review of medical records (N=346). Although no treatment-associated complications were documented, 31 (9%) patients who received OMT had documented treatment-associated aggravations. The authors conclude that OMT appears to be a safe treatment modality in the pediatric population.

Botulinum Toxin in Primary Care Medicine: Eric S. Felber
J Am Osteopath Assoc 2006 106:609-614. [Abstract] [Full Text] [PDF]
Clostridium botulinum is a gram-positive anaerobic bacterium that produces a very potent neurotoxin, causing muscle paralysis. The author discusses the biochemical mechanisms by which botulinum toxin type A can be used in the primary care setting to treat allergic rhinitis, hyperhidrosis, lichen simplex, migraine, myofascial pain syndrome, and certain task-specific idiopathic focal dystonias. The action of botulinum toxin type A on acetylcholine in the autonomic nervous system as well as its antispasmodic properties make the toxin a clinically useful agent in the management of many conditions.

Patient Confidentiality vs Disclosure of Inheritable Risk: A Survey-Based Study: Edmund L. Erde, Michael K. McCormack, Robert A. Steer, Carman A. Ciervo, Jr, and Gary N. McAbee
J Am Osteopath Assoc 2006 106:615-620. [Abstract] [Full Text] [PDF]
Should physicians continue to protect patient confidentiality when a patient is diagnosed with a genetic disease that his or her children are at risk of inheriting? When surveyed, osteopathic family physicians in New Jersey agreed that they would inform at-risk adult children with genetic predispositions if the disease were treatable; they would not inform patient offspring younger than 18 years. Most respondents preferred that state laws permit disclosure rather than require it, and they did not think state laws should forbid it. The authors encourage state regulators to develop definitive public policies.

Asymptomatic Thrombus Trapping in Vena Cava Filters: A Case Series: Oliver L. Gunter, Ronald F. Sing, Michael J. Rosen, Kent W. Kercher, and B. Todd Heniford
J Am Osteopath Assoc 2006 106:621-623. [Abstract] [Full Text] [PDF]

Like AOA Custom Publications, JAOA Now Offers Uniform Life Span for Quizzes: Carolyn Schierhorn
J Am Osteopath Assoc 2006 106:631. [Full Text] [PDF]